目录产品 » 重组蛋白 » 细胞因子 » BMP-2, Human
BMP-2, Human

Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is typically 0.07- 0.20 ug/mL.

BMP-2, Human

Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.20- 1.00 ug/mL.

BMP-2, Human

GenScript product showed better activity compared to competitor P

BMP-2, Human

2 μg of BMP-2, Human (Cat. No. Z02913) was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie Blue staining.

BMP-2, Human

Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.10-0.80 ug/mL.

BMP-2, Human

Biological Activity
BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is typically 0.07-0.20 ug/mL.

BMP-2, Human

Human Bone Morphogenetic Protein-2 (BMP-2) is a bone-growth regulatory factor and belongs to the transforming growth factor-beta (TGF-beta) superfamily. Human Bone Morphogenetic Protein-2 (BMP-2) is synthesized as large precursor molecule (Met1-Arg396, with a signal peptide from Met1 to Gly23), propeptide (Leu24-Arg282) of which is cleaved by PCSK5 (Proprotein Convertase Subtilisin/Kexin type 5). The active form consists of a dimer of two identical proteins which are linked by a disulfide bond at Cys360. It plays an important role in the development of bone and cartilage, cardiac cell differentiation and epithelial to mesenchymal transition. It is also involved in the hedgehog pathway, TGF-beta signaling pathway, and in cytokine-cytokine receptor interaction.
Z02913
¥600

联系我们
Species Human
Protein Construction
BMP-2 (Gln283-Arg396)
Accession # P12643
Purity > 95% as analyzed by SDS-PAGE
> 95% as analyzed by HPLC
Endotoxin Level < 1 EU/μg of protein by gel clotting method
Biological Activity Assay #1: Measured by its ability to induce alkaline phosphatase production by ATDC-5 Cells. The ED50 for this effect is typically 0.07-0.2 µg/ml.Assay #2: Measured by its ability to induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.2-1 µg/ml.
Expression System E. coli
Apparent Molecular Weight ~26 kDa, on SDS-PAGE under non-reducing conditions.
Formulation Lyophilized after extensive dialysis against 50 mM acetic acid.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in 20 mM AcOH or 5 mM HCl up to 100 μg/ml.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.

  • BMP-2, Human
  • BMP-2, Human

    Biological Activity
    BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is typically 0.07- 0.20 ug/mL.

  • BMP-2, Human
  • BMP-2, Human

    Biological Activity
    BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.20- 1.00 ug/mL.

  • BMP-2, Human
  • BMP-2, Human

    GenScript product showed better activity compared to competitor P

  • BMP-2, Human
  • BMP-2, Human

    2 μg of BMP-2, Human (Cat. No. Z02913) was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie Blue staining.

  • BMP-2, Human
  • BMP-2, Human

    Biological Activity
    BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by C2C12 cells. The ED50 for this effect is typically 0.10-0.80 ug/mL.

  • BMP-2, Human
  • BMP-2, Human

    Biological Activity
    BMP-2, Human (Cat. No. Z02913) induce alkaline phosphatase production by ATDC5 cells. The ED50 for this effect is typically 0.07-0.20 ug/mL.


Target Background Human Bone Morphogenetic Protein-2 (BMP-2) is a bone-growth regulatory factor and belongs to the transforming growth factor-beta (TGF-beta) superfamily. Human Bone Morphogenetic Protein-2 (BMP-2) is synthesized as large precursor molecule (Met1-Arg396, with a signal peptide from Met1 to Gly23), propeptide (Leu24-Arg282) of which is cleaved by PCSK5 (Proprotein Convertase Subtilisin/Kexin type 5). The active form consists of a dimer of two identical proteins which are linked by a disulfide bond at Cys360. It plays an important role in the development of bone and cartilage, cardiac cell differentiation and epithelial to mesenchymal transition. It is also involved in the hedgehog pathway, TGF-beta signaling pathway, and in cytokine-cytokine receptor interaction.
Synonyms BMP-2; BMP2A; Bone morphogenetic protein 2; BMP-2A; BMP2

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*